aspirin has been researched along with s 1743 in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (25.00) | 29.6817 |
| 2010's | 31 (70.45) | 24.3611 |
| 2020's | 2 (4.55) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, FK; Chan, HL; Ching, JY; Chung, SC; Hui, AJ; Hung, LC; Kung, NN; Lau, JY; Lee, KK; Lee, VW; Lee, YT; Leung, VK; Leung, WK; Sung, JJ; To, KF; Wong, VW; Wu, JC | 1 |
| Mössner, J; Nitschmann, S | 1 |
| Archimandritis, A; Cokkinos, D; Elisaf, MS; Kiskinis, D; Liberopoulos, EN; Mikhailidis, DP; Tselepis, AD | 1 |
| Kaur, B; Levine, D; Sood, S; Traxler, B; Triadafilopoulos, G; Weston, A | 1 |
| Chan, AO; Chu, KM; Fung, TT; Hu, WH; Hui, WM; Hung, WK; Kwok, KF; Lai, KC; Lam, SK; Loo, CK; Wong, BC; Wong, J | 1 |
| Johansen, M | 1 |
| Hawkey, C; Karamanolis, D; Labenz, J; Lanas, A; Nauclér, E; Rácz, I; Roda, E; Svedberg, LE; Tchernev, K; van Rensburg, C; van Zanten, SV; Yeomans, N | 1 |
| Chilton, AP; Das, D; Jankowski, JA | 1 |
| Lundberg, GD | 1 |
| Braun, S; Hadamitzky, M; Kastrati, A; Morath, T; Schömig, A; Sibbing, D; Stegherr, J; Vogt, W; von Beckerath, N | 1 |
| Andersson, T; Naesdal, J; Nauclér, E; Niazi, M; Sundin, M | 1 |
| Cui, RL; Dong, XY; Lin, SR; Xue, Y; Zhang, DH; Zhou, LY | 1 |
| Börgel, J; Endres, HG; Engelhardt, A; Krüger, JC; Lask, S; Mügge, A; Neubauer, H | 1 |
| Andersson, T; Nauclér, E; Niazi, M; Næsdal, J | 1 |
| Devereaux, PJ; Herlitz, J; Katelaris, PH; Lanas, A; Nauclér, E; Scheiman, JM; Svedberg, LE; Veldhuyzen van Zanten, S | 1 |
| Bassler, N; Dart, AM; Fernando, H; Habersberger, J; Peter, KH; Sharma, R; Shaw, JA; Sheffield, LJ | 1 |
| Cerboni, P; Doyen, D; Ferrari, E; Moceri, P | 1 |
| Yeomans, ND | 1 |
| Chen, PF; Hsiao, FY; Huang, WF; Mullins, CD; Tsai, YW; Wen, YW | 1 |
| Angiolillo, DJ; Datto, C; Desai, B; Hwang, C; Sostek, M | 1 |
| Chan, K; Chu, WM; Keung, KK; Kng, C; Kwan, A; Lam, KF; Lau, YK; Li, A; Ng, FH; Tunggal, P; Wong, BC | 1 |
| Burness, CB; Scott, LJ | 1 |
| Chen, WC; Ger, LP; Hsu, PI; Lai, KH; Lin, SY; Liu, CP; Mar, GY | 1 |
| Andersson, T; Morrison, D; Nagy, P; Pisupati, J; Schettler, J; Warner, TD | 1 |
| Bateman, A; Going, J; Goldin, R; Grabsch, H; Harrison, R; Jankowski, J; Mapstone, N; Novelli, M; Sanders, DS; Walker, MM | 1 |
| Buttar, NS; Chak, A; Corley, DA; Cruz-Correa, MR; Della'Zanna, G; Demars, CJ; Devault, KR; Falk, GW; Fleischer, DE; Foster, NR; Hur, C; Limburg, PJ; Mandrekar, SJ; Marcon, NE; Richmond, E; Romero, Y; Schnell, T; Sharma, P; Smyrk, TC; Weinberg, DS; Ziegler, KL | 1 |
| Bardou, M; Barkun, AN; Goirand, F; Hamza, S; Le Ray, I | 1 |
| Agewall, S; Herlitz, J; Lanas, A; Nagy, P; Nauclér, EC; Scheiman, JM; Svedberg, LE; Veldhuyzen van Zanten, SJ | 1 |
| Cheng, JW; Mehra, MR; Sylvester, KW | 1 |
| Chang, CY; Chiang, CE; Chiba, T; Choi, MG; Date, M; Fukushima, Y; Goto, S; Hori, M; Kim, HS; Kinoshita, Y; Lin, JT; Miwa, H; Okada, Y; Sugano, K | 1 |
| Angiolillo, DJ; Datto, C; Raines, S; Yeomans, ND | 1 |
| Andersson, T; Galbraith, H; Nagy, P; Niazi, M; Nylander, S; Ranjan, S; Wallentin, L | 1 |
| Baldycheva, I; Lanas, A; Nagy, P; Scheiman, JM; Svedberg, LE; Veldhuyzen van Zanten, S | 1 |
| Akasaka, T; Arima, Y; Hokimoto, S; Kaikita, K; Kumagae, N; Morita, K; Nakagawa, K; Ogawa, H; Oniki, K; Sakamoto, K; Tabata, N; Tsujita, K; Yamamoto, E | 1 |
| Cheng, K; Guo, WY; Liu, LP; Si, R; Wang, Y; Yuan, M | 1 |
| Grove, EL; Würtz, M | 1 |
| Bao, W; Borer, JS; Graham, DY; Husni, ME; Libby, P; Lincoff, AM; Lüscher, TF; Nissen, SE; Solomon, DH; Stevens, T; Vargo, J; Walker, C; Wang, Q; Wisniewski, LM; Wolski, KE; Yeomans, ND | 1 |
| Ang, Y; Attwood, S; Barr, H; Bhandari, P; Brooks, C; de Caestecker, J; Harrison, R; Jankowski, JAZ; Love, SB; Moayyedi, P; Morris, D; Reilly, G; Sanders, S; Watson, P | 1 |
| Marshall, JK | 1 |
| Corley, DA; Fitzgerald, RC | 1 |
| Higashi, T; Inoue, R; Mitsutake, T; Morinaga, Y; Nii, K | 1 |
| Chen, C; Huang, S; Lin, D; Luo, Y; Wu, Y; Yu, W | 1 |
| Higuchi, K; Hirata, Y; Kakimoto, K; Kinoshita, N; Kojima, Y; Koshiba, R; Miyazaki, T; Nakamura, S; Ota, K; Takeuchi, T; Tanaka, Y; Tawa, H; Tsujimoto, H; Ueda, Y | 1 |
| Deguchi, H; Fernandez, J; Igarashi, A; Ishii, M; Kawai, T; Suzuki, M; Tsujita, K | 1 |
8 review(s) available for aspirin and s 1743
| Article | Year |
|---|---|
Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?
Topics: Aspirin; Clopidogrel; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine | 2006 |
Chemoprevention of oesophageal cancer and the AspECT trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Clinical Trials as Topic; Esomeprazole; Esophageal Neoplasms; Humans | 2009 |
Reducing the risk of gastroduodenal ulcers with a fixed combination of esomeprazole and low-dose acetyl salicylic acid.
Topics: Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Cerebrovascular Disorders; Drug Therapy, Combination; Esomeprazole; Humans; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Risk | 2011 |
Acetylsalicylic acid/esomeprazole fixed-dose combination.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Capsules; Cardiovascular Diseases; Drug Combinations; Esomeprazole; Humans; Peptic Ulcer; Platelet Aggregation Inhibitors; Prodrugs; Proton Pump Inhibitors | 2012 |
Pharmacokinetic and clinical evaluation of esomeprazole and ASA for the prevention of gastroduodenal ulcers in cardiovascular patients.
Topics: Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Drug Interactions; Esomeprazole; Humans; Peptic Ulcer; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic | 2012 |
Esomeprazole and aspirin fixed combination for the prevention of cardiovascular events.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Esomeprazole; Female; Gastrointestinal Diseases; Humans; Male; Medication Adherence; Middle Aged; Patient Selection; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Quality of Life; Risk Factors; Treatment Outcome | 2013 |
Effect of esomeprazole on gastroduodenal erosions in patients at increased gastrointestinal risk treated with low-dose acetylsalicylic acid: a post-hoc analysis of the OBERON trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Esomeprazole; Gastrointestinal Hemorrhage; Global Health; Humans; Incidence; Peptic Ulcer; Proton Pump Inhibitors; Risk Assessment | 2015 |
Proton Pump Inhibitors in Cardiovascular Disease: Drug Interactions with Antiplatelet Drugs.
Topics: Adenosine; Aspirin; Cardiovascular Diseases; Clopidogrel; Drug Administration Schedule; Drug Dosage Calculations; Drug Interactions; Esomeprazole; Gastrointestinal Hemorrhage; Gene Expression; Humans; Hydrogen-Ion Concentration; Peptic Ulcer; Prasugrel Hydrochloride; Proton Pump Inhibitors; Purinergic Antagonists; Receptors, Purinergic P2Y12; Ticagrelor; Ticlopidine | 2017 |
24 trial(s) available for aspirin and s 1743
| Article | Year |
|---|---|
Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.
Topics: Aged; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Secondary Prevention; Ticlopidine | 2005 |
The effects of esomeprazole combined with aspirin or rofecoxib on prostaglandin E2 production in patients with Barrett's oesophagus.
Topics: Adult; Aged; Aspirin; Barrett Esophagus; Cross-Over Studies; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Drug Therapy, Combination; Enzyme Inhibitors; Esomeprazole; Esophagitis; Esophagus; Female; Humans; Lactones; Male; Middle Aged; Proliferating Cell Nuclear Antigen; Prospective Studies; Sulfones | 2006 |
Esomeprazole with aspirin versus clopidogrel for prevention of recurrent gastrointestinal ulcer complications.
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Aspirin; Clopidogrel; Cohort Studies; Double-Blind Method; Esomeprazole; Female; Humans; Male; Middle Aged; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Secondary Prevention; Stomach Ulcer; Ticlopidine; Treatment Outcome | 2006 |
Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Global Health; Humans; Incidence; Male; Peptic Ulcer; Retrospective Studies; Risk Factors; Treatment Outcome | 2008 |
Evaluation of the pharmacokinetic interaction between esomeprazole (40 mg) and acetylsalicylic acid (325 mg) in healthy volunteers.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Area Under Curve; Aspirin; Cross-Over Studies; Drug Interactions; Esomeprazole; Female; Humans; Male; Middle Aged; Young Adult | 2009 |
Pantoprazole does not influence the antiplatelet effect of clopidogrel-a whole blood aggregometry study after coronary stenting.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Artery Disease; Drug Interactions; Esomeprazole; Female; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Proton Pump Inhibitors; Regression Analysis; Stents; Ticlopidine | 2010 |
Evaluation of bioequivalence between a single-capsule formulation of esomeprazole 40 mg and acetylsalicylic acid 325 mg and the monotherapies given separately in healthy volunteers.
Topics: Adult; Aspirin; Capsules; Cross-Over Studies; Drug Combinations; Esomeprazole; Female; Humans; Male; Therapeutic Equivalency | 2011 |
Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON).
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Aspirin; Esomeprazole; Female; Humans; Male; Middle Aged; Peptic Ulcer; Young Adult | 2011 |
Randomized double-blind placebo-controlled crossover study to determine the effects of esomeprazole on inhibition of platelet function by clopidogrel.
Topics: Acute Coronary Syndrome; Aged; Aryl Hydrocarbon Hydroxylases; Aspirin; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Cross-Over Studies; Cytochrome P-450 CYP2C19; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Genotype; Humans; Male; Microfilament Proteins; Middle Aged; Phenotype; Phosphoproteins; Placebo Effect; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Proton Pump Inhibitors; Risk Assessment; Ticlopidine; Time Factors; Victoria | 2011 |
Doubling the dose of clopidogrel restores the loss of antiplatelet effect induced by esomeprazole.
Topics: Aged; Anti-Ulcer Agents; Aspirin; Clopidogrel; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Function Tests; Ranitidine; Ticlopidine | 2011 |
Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Combinations; Esomeprazole; Female; Humans; Male; Middle Aged; Naproxen; Pilot Projects; Placebos; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Tablets, Enteric-Coated; Thromboxane B2; Time Factors; United States | 2011 |
Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction.
Topics: Acute Coronary Syndrome; Aged; Anti-Ulcer Agents; Aspirin; Chi-Square Distribution; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Enoxaparin; Esomeprazole; Famotidine; Female; Fibrinolytic Agents; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intestinal Perforation; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Ticlopidine; Treatment Outcome | 2012 |
Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers.
Topics: Aged; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Chi-Square Distribution; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Peptic Ulcer; Platelet Aggregation Inhibitors; Risk Factors; Surveys and Questionnaires; Taiwan; Treatment Outcome | 2012 |
Evaluation of the pharmacodynamics of acetylsalicylic acid 81 mg with or without esomeprazole 20 mg in healthy volunteers.
Topics: Adolescent; Adult; Aged; Aspirin; Cross-Over Studies; Drug Interactions; Esomeprazole; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Thromboxane B2; Young Adult | 2012 |
Comparing virtual with conventional microscopy for the consensus diagnosis of Barrett's neoplasia in the AspECT Barrett's chemoprevention trial pathology audit.
Topics: Anti-Ulcer Agents; Aspirin; Barrett Esophagus; Disease Progression; Esomeprazole; Esophageal Neoplasms; Esophagoscopy; Humans; Microscopy; Observer Variation; Reproducibility of Results; Telepathology; User-Computer Interface | 2012 |
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Barrett Esophagus; Biomarkers; Biopsy; Cyclooxygenase Inhibitors; Dinoprostone; Double-Blind Method; Down-Regulation; Drug Therapy, Combination; Esomeprazole; Esophagoscopy; Esophagus; Female; Humans; Male; Middle Aged; Proton Pump Inhibitors | 2012 |
Esomeprazole for prevention and resolution of upper gastrointestinal symptoms in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: the OBERON trial.
Topics: Age Factors; Aged; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Dose-Response Relationship, Drug; Double-Blind Method; Dyspepsia; Esomeprazole; Female; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Secondary Prevention; Self Report; Upper Gastrointestinal Tract | 2013 |
Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER study.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Asian People; Aspirin; Double-Blind Method; Drug Administration Schedule; Esomeprazole; Female; Humans; Japan; Kaplan-Meier Estimate; Male; Middle Aged; Peptic Ulcer; Prospective Studies; Republic of Korea; Secondary Prevention; Taiwan; Treatment Outcome | 2014 |
Impact of concomitant low-dose aspirin on the safety and tolerability of naproxen and esomeprazole magnesium delayed-release tablets in patients requiring chronic nonsteroidal anti-inflammatory drug therapy: an analysis from 5 Phase III studies.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Aspirin; Delayed-Action Preparations; Double-Blind Method; Esomeprazole; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Naproxen; Osteoarthritis | 2014 |
Effect of esomeprazole with/without acetylsalicylic acid, omeprazole and lansoprazole on pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteers.
Topics: Adolescent; Adult; Area Under Curve; Aspirin; Clopidogrel; Cross-Over Studies; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Healthy Volunteers; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Platelet Aggregation; Proton Pump Inhibitors; Ticlopidine; Young Adult | 2014 |
Esomeprazole and rabeprazole did not reduce antiplatelet effects of aspirin/clopidogrel dual therapy in patients undergoing percutaneous coronary intervention: a prospective, randomized, case-control study.
Topics: Aged; Aspirin; Case-Control Studies; Cell Adhesion Molecules; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Microfilament Proteins; Middle Aged; Percutaneous Coronary Intervention; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Ticlopidine | 2016 |
Randomised clinical trial: gastrointestinal events in arthritis patients treated with celecoxib, ibuprofen or naproxen in the PRECISION trial.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Aspirin; Celecoxib; Double-Blind Method; Drug Therapy, Combination; Esomeprazole; Female; Gastrointestinal Diseases; Humans; Ibuprofen; Male; Middle Aged; Naproxen; Osteoarthritis; Treatment Outcome | 2018 |
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Barrett Esophagus; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Middle Aged; Proton Pump Inhibitors; Young Adult | 2018 |
Effect of a proton-pump inhibitor on intestinal microbiota in patients taking low-dose aspirin.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Case-Control Studies; Comorbidity; Dose-Response Relationship, Drug; Esomeprazole; Female; Gastrins; Gastrointestinal Hemorrhage; Gastrointestinal Microbiome; Hematocrit; Hemoglobins; Humans; Intestinal Mucosa; Lactobacillales; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Sulfonamides | 2021 |
12 other study(ies) available for aspirin and s 1743
| Article | Year |
|---|---|
[ASS or clopidogrel plus esomeprazole after bleeding from an ulcer].
Topics: Aged; Anti-Ulcer Agents; Aspirin; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Peptic Ulcer Hemorrhage; Platelet Aggregation Inhibitors; Prospective Studies; Proton Pump Inhibitors; Secondary Prevention; Ticlopidine | 2005 |
[Antiplatelet therapy after aspirin-induced upper gastrointestinal bleeding].
Topics: Anti-Ulcer Agents; Aspirin; Clopidogrel; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Esomeprazole; Evidence-Based Medicine; Fibrinolytic Agents; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Ticlopidine | 2006 |
Esomeprazole prevents aspirin-induced ulcers.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dose-Response Relationship, Drug; Double-Blind Method; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Esomeprazole; Female; Follow-Up Studies; Humans; Incidence; Male; Peptic Ulcer; Retrospective Studies; Risk Factors; Treatment Outcome | 2008 |
Impact of proton pump inhibitors on the antiplatelet effects of clopidogrel.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Cross-Sectional Studies; Drug Interactions; Drug Therapy, Combination; Esomeprazole; Female; Humans; Male; Middle Aged; Multivariate Analysis; Omeprazole; Pantoprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Proton Pump Inhibitors; Stents; Ticlopidine | 2009 |
Factors influencing intercellular spaces in the rat esophageal epithelium.
Topics: Animals; Aspirin; Biopsy; Esomeprazole; Esophagus; Ethanol; Extracellular Space; Hydrochloric Acid; Male; Microscopy, Electron, Transmission; Mucous Membrane; Prednisolone; Proton Pump Inhibitors; Rats; Rats, Sprague-Dawley; Restraint, Physical; Stress, Psychological | 2010 |
Relationship between cardiovascular outcomes and proton pump inhibitor use in patients receiving dual antiplatelet therapy after acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Aryl Hydrocarbon Hydroxylases; Aspirin; Cardiovascular Diseases; Clopidogrel; Cohort Studies; Cytochrome P-450 CYP2C19; Databases, Factual; Drug Interactions; Esomeprazole; Female; Herb-Drug Interactions; Hospitalization; Humans; Male; Middle Aged; Omeprazole; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Recurrence; Retrospective Studies; Ticlopidine; Treatment Outcome | 2011 |
Impact of esomeprazole on platelet reactivity and clinical outcome according to CYP2C19 genotype in coronary heart disease patients during dual antiplatelet therapy.
Topics: Aged; Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Coronary Disease; Cytochrome P-450 CYP2C19; Esomeprazole; Ethnicity; Female; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Prospective Studies; Proton Pump Inhibitors; Ticlopidine; Treatment Outcome | 2015 |
In Barrett esophagus, high- vs low-dose esomeprazole improved clinical outcomes; aspirin vs no aspirin did not.
Topics: Aspirin; Barrett Esophagus; Drug Therapy, Combination; Esomeprazole; Humans; Proton Pump Inhibitors | 2018 |
Will a Proton Pump Inhibitor and an Aspirin Keep the Doctor Away for Patients With Barrett's Esophagus?
Topics: Aspirin; Barrett Esophagus; Esomeprazole; Esophageal Neoplasms; Humans; Proton Pump Inhibitors | 2019 |
Different Clopidogrel Response Elicited by Lansoprazole or Esomeprazole in Patients Undergoing Neurointervention with Dual Antiplatelet Therapy.
Topics: Aged; Aged, 80 and over; Aspirin; Clopidogrel; Dual Anti-Platelet Therapy; Esomeprazole; Female; Humans; Lansoprazole; Male; Middle Aged; Neurosurgical Procedures; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Retrospective Studies; Thromboembolism | 2019 |
The effect of esomeprazole vs famotidine on aspirin/clopidogrel dual therapy after percutaneous coronary intervention.
Topics: Aspirin; Blood Platelets; Clopidogrel; Drug Therapy, Combination; Esomeprazole; Famotidine; Humans; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Ticlopidine; Treatment Outcome | 2019 |
Cost-Effectiveness of Vonoprazan Compared With Proton Pump Inhibitors in Patients Taking Low-Dose Aspirin for Secondary Prevention of Cardiovascular Events in Japan.
Topics: Aged; Aspirin; Cardiovascular Diseases; Cost-Benefit Analysis; Esomeprazole; Gastrointestinal Hemorrhage; Humans; Japan; Lansoprazole; Proton Pump Inhibitors; Pyrroles; Secondary Prevention | 2023 |